Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
118.26
+0.39 (0.33%)
Apr 28, 2026, 11:10 AM EDT - Market open
Zoetis Market Cap
Zoetis has a market cap or net worth of $49.73 billion as of April 28, 2026. Its market cap has decreased by -24.45% in one year.
Market Cap
49.73B
Enterprise Value
56.42B
1-Year Change
-24.45%
Ranking
Category
Stock Price
$118.26
Market Cap Chart
Since February 1, 2013, Zoetis's market cap has increased from $15.51B to $49.73B, an increase of 220.74%. That is a compound annual growth rate of 9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 49.76B | -10.27% |
| Dec 31, 2025 | 55.45B | -24.57% |
| Dec 31, 2024 | 73.51B | -18.88% |
| Dec 29, 2023 | 90.62B | 32.67% |
| Dec 30, 2022 | 68.30B | -40.84% |
| Dec 31, 2021 | 115.46B | 46.79% |
| Dec 31, 2020 | 78.66B | 24.78% |
| Dec 31, 2019 | 63.04B | 53.39% |
| Dec 31, 2018 | 41.10B | 17.07% |
| Dec 29, 2017 | 35.10B | 32.79% |
| Dec 30, 2016 | 26.43B | 10.79% |
| Dec 31, 2015 | 23.86B | 10.61% |
| Dec 31, 2014 | 21.57B | 31.98% |
| Dec 31, 2013 | 16.35B | 5.42% |
| Feb 1, 2013 | 15.51B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 52.47B |
| Haleon | 42.24B |
| Teva Pharmaceutical Industries | 36.78B |
| United Therapeutics | 24.92B |
| Viatris | 17.24B |
| Regencell Bioscience Holdings | 14.34B |
| Neurocrine Biosciences | 13.03B |
| Dr. Reddy's Laboratories | 11.99B |